1-11 of 11
Paolo Ubezio
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models

Free
Marina Meroni, Ilaria Craparotta, Federica Mirimao, Nicolò Panini, Paolo Ubezio, Ezia Bello, Salvatore Lorenzo Renne, Maurizio D'Incalci, Roberta Frapolli
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 7199.
https://doi.org/10.1158/1538-7445.AM2024-7199
Published: 22 March 2024
View articletitled, Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models
Journal Articles

Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer

Available to Purchase
Francesca Falcetta, Francesca Bizzaro, Elisa D'Agostini, Maria Rosa Bani, Raffaella Giavazzi, Paolo Ubezio
Journal: Cancer Research
Cancer Res (2017) 77 (23): 6759–6769.
https://doi.org/10.1158/0008-5472.CAN-17-1099
Published: 30 November 2017
View articletitled, Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer
Open the PDF for Modeling Cytostatic and Cytotoxic Responses to New Treatment Regimens for Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 4821: The WEE1 inhibitor AZD-1775 has synergic activity with trabectedin or lurbinectedin in ovarian cancer cells

Free
Sarah Uboldi, Laura Carrassa, Roberta Frapolli, Paolo Ubezio, Eugenio Erba, Maurizio D’Incalci
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4821.
https://doi.org/10.1158/1538-7445.AM2016-4821
Published: 15 July 2016
View articletitled, Abstract 4821: The WEE1 inhibitor AZD-1775 has synergic activity with trabectedin or lurbinectedin in ovarian cancer cells
Journal Articles

Abstract 3777: In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells

Free
Monica Lupi, Francesca Falcetta, Maurizio D'Incalci, Paolo Ubezio
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3777.
https://doi.org/10.1158/1538-7445.AM2015-3777
Published: 01 August 2015
View articletitled, Abstract 3777: In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells
Journal Articles

Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates

Available to Purchase
Marco Mazzoletti, Francesca Bortolin, Laura Brunelli, Roberta Pastorelli, Silvana Di Giandomenico, Eugenio Erba, Paolo Ubezio, Massimo Broggini
Journal: Cancer Research
Cancer Res (2011) 71 (13): 4573–4584.
https://doi.org/10.1158/0008-5472.CAN-10-4322
Published: 30 June 2011
View articletitled, Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates
Open the PDF for Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates in another window
Includes: Supplementary data
Journal Articles

Abstract 3289: PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models

Free
Katiuscia Bonezzi, Roberta Frapolli, Federica Sala, Lucile Astorgues-Xerri, Maria Serova, Eric Raymond, Esteban Cvitkovic, Kay Noel, Paolo Ubezio, Massimo Zucchetti, Maurizio D'Incalci, Raffaella Giavazzi, Giulia Taraboletti
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 3289.
https://doi.org/10.1158/1538-7445.AM2011-3289
Published: 15 April 2011
View articletitled, Abstract 3289: PTX-008, a dual inhibitor of angiogenesis and tumor cell proliferation, potentiates the antineoplastic activity of targeted therapies in human tumor models
Journal Articles

Quantitative Assessment of the Complex Dynamics of G1, S, and G2-M Checkpoint Activities

Available to Purchase
Paolo Ubezio, Monica Lupi, Davide Branduardi, Paolo Cappella, Edoardo Cavallini, Valentina Colombo, Giada Matera, Claudia Natoli, Daniela Tomasoni, Maurizio D'Incalci
Journal: Cancer Research
Cancer Res (2009) 69 (12): 5234–5240.
https://doi.org/10.1158/0008-5472.CAN-08-3911
Published: 15 June 2009
View articletitled, Quantitative Assessment of the Complex Dynamics of G1, S, and G2-M Checkpoint Activities
Open the PDF for Quantitative Assessment of the Complex Dynamics of G1, S, and G2-M Checkpoint Activities in another window
Includes: Supplementary data
Journal Articles

Cytostatic and Cytotoxic Effects of Topotecan Decoded by a Novel Mathematical Simulation Approach

Available to Purchase
Monica Lupi, Giada Matera, Davide Branduardi, Maurizio D’Incalci, Paolo Ubezio
Journal: Cancer Research
Cancer Res (2004) 64 (8): 2825–2832.
https://doi.org/10.1158/0008-5472.CAN-03-3810
Published: 15 April 2004
View articletitled, Cytostatic and Cytotoxic Effects of Topotecan Decoded by a Novel Mathematical Simulation Approach
Open the PDF for Cytostatic and Cytotoxic Effects of Topotecan Decoded by a Novel Mathematical Simulation Approach in another window
Journal Articles

Combination of angiogenic inhibitors and chemotherapeutic agents on human endothelium

Free
Elitza Naumova, Maria I. Nicoletti, Angela Garofalo, Romina Dossi, Paolo Ubezio, Raffaella Giavazzi
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 594.
Published: 01 April 2004
View articletitled, Combination of angiogenic inhibitors and chemotherapeutic agents on human endothelium
Journal Articles

Increasing 1-β-d-Arabinofuranosylcytosine Efficacy by Scheduled Dosing Intervals Based on Direct Measurements of Bone Marrow Cell Kinetics1

Available to Purchase
Paolo Ubezio, Giovanna Tagliabue, Bila Schechter, Zvia Agur
Journal: Cancer Research
Cancer Res (1994) 54 (24): 6446–6451.
Published: 01 December 1994
View articletitled, Increasing 1-β-d-Arabinofuranosylcytosine Efficacy by Scheduled Dosing Intervals Based on Direct Measurements of Bone Marrow Cell Kinetics1
Open the PDF for Increasing 1-β-d-Arabinofuranosylcytosine Efficacy by Scheduled Dosing Intervals Based on Direct Measurements of Bone Marrow Cell Kinetics1 in another window
Journal Articles

Comparison of Histone Variant Synthesis in Human Lymphocytic Leukemia Cells and in Normal Lymphocytes

Available to Purchase
Cecilia Mannironi, Vincenzo Rossi, Andrea Biondi, Paolo Ubezio, Giovanni Giudici, Giuseppe Masera, Maurizio D'Incalci
Journal: Cancer Research
Cancer Res (1988) 48 (13): 3670–3675.
Published: 01 July 1988
View articletitled, Comparison of Histone Variant Synthesis in Human Lymphocytic Leukemia Cells and in Normal Lymphocytes
Open the PDF for Comparison of Histone Variant Synthesis in Human Lymphocytic Leukemia Cells and in Normal Lymphocytes in another window